Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation LEXINGTON, Mass. – May 22, 2012 – Avaxia Biologics, Inc., a privately-held biotech - Mucositis - Document - PDFSEARCH.IO

First Page	Meta Content
	Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation LEXINGTON, Mass. – May 22, 2012 – Avaxia Biologics, Inc., a privately-held biotech Add to Reading List Document Date: 2014-02-06 00:38:27 Open Document File Size: 87,83 KB Share Result on Facebook City LEXINGTON / / Company Avaxia Biologics Inc. / / Currency USD / / Event Patent Issuance / / IndustryTerm therapy for cancer / privately-held biotechnology company developing oral antibody drugs / / MedicalCondition mucositis / celiac disease / inflammatory bowel disease / obesity / cancer / GI acute radiation syndrome / gastrointestinal acute radiation syndrome / disease / AVX Oral Antibodies make diseases / oral mucositis / diabetes / / MedicalTreatment radiation therapy / total body irradiation / Radiation / / Organization Biomedical Advanced Research and Development Authority / / Person Barbara Fox / / Position CEO / / ProvinceOrState Massachusetts / / Technology Radiation / Antibodies / biotechnology / / SocialTag Radiobiology Immunology Monoclonal antibodies Mucositis Immune system Radiation therapy Acute radiation syndrome Monoclonal antibody therapy TNF inhibitor Medicine

Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation LEXINGTON, Mass. – May 22, 2012 – Avaxia Biologics, Inc., a privately-held biotechAdd to Reading List